← Open Payments lookup

CARL BLACK: Open Payments

NPI 1336723840 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,812 in 82 payments from 16 companies in 2025. Trend: 2023 $2,330 · 2024 $1,851 · 2025 $1,812

Food & beverage: $1,812
CompanyPaymentsAmount
Novo Nordisk Inc11$271
GlaxoSmithKline, LLC.10$231
AstraZeneca Pharmaceuticals LP10$215
PFIZER INC.9$189
Lilly USA, LLC6$150
Astellas Pharma US Inc7$149
ABBVIE INC.9$141
Boehringer Ingelheim Pharmaceuticals, Inc.4$91
Bayer Healthcare Pharmaceuticals Inc.5$86
Dexcom, Inc.2$77

Products named: TRELEGY ELLIPTA, NURTEC ODT, Ozempic, MOUNJARO, Veozah, JARDIANCE, BREZTRI, Kerendia.

Industry payments across PA — which companies pay providers there.